NETHERLANDS Law and Practice Contributed by: Rutger Kleemans, Jelle Drok, Ruben Laddé and Allard van Duijn, Freshfields
Freshfields is known for representing corpo- rates that are at the forefront of innovation. The Amsterdam IP team serves top-tier clients in- cluding Novartis, Moderna, Genentech, Roche, Alexion, AstraZeneca, HP, Xiaomi and Apple. The team, consisting of 11 lawyers, is renowned for its expertise in life sciences, pharma, chemi- cal, and complex technology matters, handling a significant percentage of patent litigation cases both before national courts and at the UPC. Recent landmark cases include Moder- na’s litigation against Pfizer and BioNTech and
Novartis’ extensive litigation against Pharma- then. The Amsterdam team works seamlessly across Freshfields’ global network, most fre- quently collaborating with the key patent litiga- tion offices in London, Düsseldorf and Munich. The pan-European patent litigation and en- forcement capabilities enable the team to pro- vide consistent, high-quality representation in complex cases spanning multiple jurisdictions. In addition to its litigation expertise, the team also advises on IP matters in complex and in- ternational transactions.
Authors
Rutger Kleemans is a partner at the Freshfields IP practice, leading the Amsterdam team and serving as co-head of the firm’s life sciences sector group. Recognised as one of Europe’s
Jelle Drok is a partner at the Freshfields Amsterdam IP practice, focusing on patent litigation with an emphasis on technology, including semiconductors,
leading patent litigators, he represents clients in high-profile cases before Dutch and pan- European courts, including the UPC. Rutger serves as lead counsel in various heavy-hitting patent litigation proceedings, including for Moderna in its widely publicised patent litigation against Pfizer and BioNTech regarding COVID-19 vaccines. He has extensive experience co-ordinating multi-jurisdictional litigation for clients such as Novartis, Genentech and Alexion. Rutger is an active member of AIPPI and EPLAW.
communications and mass claims. He has extensive experience in complex multi- jurisdictional litigation and regularly appears before Dutch courts, the UPC and the TBA of the EPO. Jelle holds a degree in Aerospace Engineering from Delft University of Technology, which underpins his strong technical expertise. His recent experience includes securing the highest penalty sum awarded by a Dutch court for Novartis and representing high-profile clients like Apple, HP and Moderna. Jelle is a member of professional IP organisations, such as AIPPI and EPLAW.
351 CHAMBERS.COM
Powered by FlippingBook